0001127602-20-015023.txt : 20200501
0001127602-20-015023.hdr.sgml : 20200501
20200501161129
ACCESSION NUMBER: 0001127602-20-015023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200429
FILED AS OF DATE: 20200501
DATE AS OF CHANGE: 20200501
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DE SCHUTTER RICHARD U
CENTRAL INDEX KEY: 0001083205
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 20840970
MAIL ADDRESS:
STREET 1: C/O MONSANTO CO
STREET 2: 800 NORTH LINDBERGH BLVD
CITY: ST LOUIS
STATE: MO
ZIP: 63167
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch Health Companies Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
DATE OF NAME CHANGE: 20100928
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-04-29
0000885590
Bausch Health Companies Inc.
BHC
0001083205
DE SCHUTTER RICHARD U
400 SOMERSET CORPORATE BOULEVARD
BRIDGEWATER
NJ
08807
1
Common Shares, No Par Value
2020-04-29
4
F
0
624
18.11
D
280642
D
Common Shares, No Par Value
2020-05-01
4
A
0
11037
0
A
291679
D
Common Shares, No Par Value
13800
I
By spouse
This number represents common shares, no par value, of the Issuer ("Common Shares") withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units ("RSUs").
Represents the award of RSUs granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $200,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in Common Shares.
/s/ Kirsten O'Donnell, attorney-in-fact for Richard U. De Schutter
2020-05-01